Delivery Order SPE2DX22D0010-SPE2D825FEZ21
Award Date
4/15/25
Potential Completion Date
4/16/25
Potential Value
$1.4K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxymorphone HCL ER Tablets 20mg, a prescription pain medication. The contract has a firm fixed price, a ceiling value of $8,605.76, and a period of performance through April 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of oxymorphone hydrochloride extended-release tablets, a medication used for pain management. The award has a ceiling value of $3,914.49 and is a firm fixed-price delivery order contract with a completion date of March 21, 2025. The contract is not designated as a set-aside....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $3,113.27 award is for the delivery of oxymorphone hydrochloride extended-release tablets, 15 milligrams. This delivery order falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 60 tablets of 10 mg Oxymorphone HCl Extended Release. The contract has a ceiling value of $1,116.34 and a period of performance ending on May 12, 2025. The award is not set aside and was made on May 9, 2025. AmerisourceBergen Drug Corp is the prime contractor and this award is part of a larger Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,150.95, is for the delivery of Oxymorphone HCL ER 20 mg tablets. The contract has an ultimate completion date of April 17, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,417.79, is for the delivery of oxymorphone hydrochloride extended-release tablets with a completion date of February 4, 2025. The contract is a firm fixed-price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oxymorphone Hydrochloride Extended-Release Tablets, 10 mg. The award, with a ceiling value of $2,096.02, is a Firm Fixed Price Delivery Order contract with a period of performance ending on September 17, 2024. This contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 10mg oxymorphone hydrochloride extended-release tablets, a pain management medication, with a ceiling value of $4,816.74 and a completion date of June 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation,...
This federal contract award, valued at $1,634.25, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of oxymorphone hydrochloride extended-release tablets, a pain management medication. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,824.02 firm fixed-price delivery order is for the supply of Oxymorphone HCL ER Tablets, 7.5 mg, with a period of performance through February 10, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...